Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glucose and potassium chloride and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only glucose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose and potassium chloride only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glucose and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glucose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glucose and potassium chloride and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 400 mg/g oral gel |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 400 mg/g oral gel |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 500 mg/mL oral solution |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 500 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 150 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 150 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 400 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 400 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only glucose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose intake |
Process acts on |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glucose and lidocaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose and lidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing glucose and potassium chloride and sodium bicarbonate and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing glucose and potassium chloride and sodium bicarbonate and sodium chloride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose and potassium chloride and sodium bicarbonate and sodium chloride only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing glucose and potassium chloride and sodium chloride and sodium citrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing glucose and potassium chloride and sodium chloride and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only glucose and potassium chloride and sodium chloride and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose and potassium chloride and sodium chloride and sodium citrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose 50 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 50 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 100 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 500 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 500 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose 100 mg/mL solution for infusion |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 100 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 100 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 100 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interstitial fluid glucose concentration (observable entity) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ambulatory continuous glucose monitoring of interstitial tissue fluid with sensor placement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ambulatory continuous glucose monitoring of interstitial tissue fluid (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose in blood one hour postprandial (observable entity) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose in blood one hour after glucose dose in pregnancy |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 40 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely glucose 50 milligram/1 milliliter and sodium chloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely calcium chloride 200 microgram, glucose 50 milligram and potassium chloride 300 microgram and sodium chloride 6 milligram and sodium lactate 3.1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing precisely calcium chloride 200 microgram, glucose 50 milligram and potassium chloride 300 microgram and sodium chloride 6 milligram and sodium lactate 3.1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing only calcium chloride and glucose and potassium chloride and sodium chloride and sodium lactate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Glucose intake |
Process acts on |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 250 mg/mL solution for injection |
Has precise active ingredient |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 250 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Blood glucose series |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluid sample glucose measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ward urine dip stick testing for sugar (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum random glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum fasting glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum 2-hr post-prandial glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma random glucose measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma fasting glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma 2-hr post-prandial glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urine glucose chemical titer measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Random blood glucose measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fasting blood glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lunch time blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Supper time blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bedtime blood sugar measurement (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Post-prandial blood glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Self-monitoring of blood glucose |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Self-monitoring of urine glucose |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Self-monitoring of blood and urine glucose |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |